PDL BIOPHARMA (NASDAQ:PDLI)
7.90
0.11 (1.37%)
| PDL BIOPHARMA (NASDAQ:PDLI) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $8.01 | 52 Week High | $9.92 | ||
| Open | $8.01 | 52 Week Low | $5.20 | ||
| Day High | $8.02 | P/E | 4.32 | ||
| Day Low | $7.85 | EPS | $1.83 | ||
| Volume | 2,836,556 | ||||
| More PDLI Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| FSLR | 3 | MTZ | 3 |
| MASI | 3 | AMPH | 2 |
| AMD | 2 | EGLE | 2 |
| PPDI | 2 | DRYS | 2 |
| JASO | 2 | IMMR | 2 |
| AFL | 2 | URBN | 2 |
Entities who have mentioned PDLI
- Dividend | View Related Stories »
- Lehman Brothers | View Related Stories »
- Goldman Sachs | View Related Stories »
- JPMorgan | View Related Stories »
- Morgan Stanley | View Related Stories »
- Credit Suisse | View Related Stories »
- Jefferies & Co | View Related Stories »
- Lazard | View Related Stories »
- Citi | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Wachovia | View Related Stories »
- Merrill Lynch | View Related Stories »
- Banc of America | View Related Stories »
- Barclays | View Related Stories »
- Crude Oil | View Related Stories »
- S&P Equity Research | View Related Stories »
- Chrysler LLC | View Related Stories »
- Apax Partners | View Related Stories »
- Baupost Group | View Related Stories »
- UBS | View Related Stories »
- Seth Klarman | View Related Stories »
- Soleil Securities | View Related Stories »
- Trading Radar | View Related Stories »
- Daniel Loeb | View Related Stories »
- Thomas Weisel Partners Group | View Related Stories »
View All Major News StreetInsider.com Major News for PDLI
- PDL BioPharma (PDLI) Reports Mixed Q3 Results; Narrows FY09 Sales Guidance
- PDL BioPharma (PDLI) Tops Q2 Views
- PDL BioPharma (PDLI) Reports Mixed Q1 Results; Re-affirms
View All ReportsStreetInsider.com Reports on PDLI
- PDL BioPharma (PDLI) Approves Special Dividend
- Trading Radar for 10/28: First Solar (FSLR), ConocoPhillips (COP), WellPoint (WLP), Goodyear (GT), Int. Paper (IP) Report
- PDL BioPharma (PDLI) Reports Mixed Q3 Results; Narrows FY09 Sales Guidance
- Trading Radar for 10/27: Visa (V), Baidu.com (BIDU), WYNN Resorts (WYNN), RF Micro (RFMD), BP (BP) Report
- PDL BioPharma (PDLI) Completes October 1 Special Dividend Payment of 50c
View All Press ReleasesCompany Press Releases on PDLI
- PDL BioPharma Announces Special Dividend Payment
- PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction
- PDL BioPharma Announces Pricing of $300,000,000 Securitization Transaction
- PDL BioPharma Announces Third Quarter 2009 Financial Results
- PDL BioPharma to Present at Oppenheimer & Co. 20th Annual Healthcare Conference on November 4, 2009
StreetInsider Reports on PDLI by Category
View All BlogsBlogs on PDLI
- Baupost Group's Q3 Portfolio: Two Changes of Note
- Baupost Initiates Enzon Position, Ups ViaSat Stake
- Two Stocks with Market Caps Over $250 Million That Sell for Under $10
- PDL BioPharma Q3 2009 Earnings Call Transcript
- Seth Klarman Sells Facet Biotech Shares and His Entire Horizon Lines Position
View All FilingsSEC Filings on PDLI
- Form 8-K PDL BIOPHARMA, INC. For: Nov 13
- Form 10-Q PDL BIOPHARMA, INC. For: Sep 30
- Form 8-K PDL BIOPHARMA, INC. For: Nov 02
- Form 4 KLEIN JOSEPH III For: Nov 04
- Form 8-K PDL BIOPHARMA, INC. For: Nov 02
Comments on recent PDLI articles
Comments on PDLI
No comments are currently available.
on Oct 28, 2009
at 05:29 PM ANDREW OLIVER SATCHELL GOOD
Article: Trading Radar for 10/27: Visa (V), Baidu.com (BIDU), WYNN Resorts (WYNN), RF Micro (RFMD), BP (BP) Report